Pharmstandard Ventures

Investor type

CVC

Founded

-

AUM

-

Location

Russia

$1-5 m

Investment Ticket

3-5 years

Investment Horizon

Series A

Investment Stage

Sale to strategic investor, IPO

Exit Strategy

Investor profile last updated: 09 February, 2026

Profile

Pharmstandard Ventures is a Venture Arm within Pharmstandard, JSC, Russia's leading pharmaceutical company.
We were formed in 2013 as Inbio Ventures, and changed our name to Pharmstandard Ventures after corporate restructuring in 2017.

Industry

Biotechnology Healthcare Services Pharmaceuticals MedTech HealthTech

Region of investment

North America South America Europe Middle East Africa Asia Australia and others

Contacts

Upgrade to see contacts
Name
Title
Email
avatar
20TnjOrAVce8wvQN 20TnjOrAVce8wvQN
20TnjOrAVce8wvQN
avatar
20TnjOrAVce8wvQN 20TnjOrAVce8wvQN
20TnjOrAVce8wvQN
avatar
20TnjOrAVce8wvQN 20TnjOrAVce8wvQN
20TnjOrAVce8wvQN
avatar
20TnjOrAVce8wvQN 20TnjOrAVce8wvQN
20TnjOrAVce8wvQN
avatar
20TnjOrAVce8wvQN 20TnjOrAVce8wvQN
20TnjOrAVce8wvQN
If there are no contacts of this investor, please write to us, we will try to find them as soon as possible and get back to you!

FAQs about Pharmstandard Ventures

Pharmstandard Ventures is located in Russia.
Pharmstandard Ventures was founded in .
Pharmstandard Ventures invests in companies and startups in Biotechnology, Healthcare Services, Pharmaceuticals, MedTech, HealthTech.
Pharmstandard Ventures invests in companies and startups in North America, South America, Europe, Middle East, Africa, Asia, Australia and others.
Pharmstandard Ventures invests in companies and startups at Series A.
Pharmstandard Ventures usually invests $1-5 m on average.